Stage III Breast Cancer: Karol's Patient Story

Patient Info: Karol | Stage III

Karol continued hormone therapy for stage 3 breast cancer after a broader treatment plan including surgery, chemotherapy, and radiation had been recommended.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Cristina's Patient Story

Patient Info: Cristina, Female, 40s | Stage II

As of 2022, Cristina was undergoing treatment for Stage II breast cancer and planned to finish treatment, return to work, and rebuild normal life with her son.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Antonia's Survivor Story

Patient Info: Antonia, Female, Under 40 | Stage III

Antonia described herself as being in remission after multimodal treatment while continuing hormone therapy. Fear of recurrence and metastatic spread remained significant.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Katie's Survivor Story

Patient Info: Katie, Female, Under 40 | Stage III

Biomarkers: Hormone-sensitive breast cancer; specific receptor results not otherwise reported

As of December 2021, Katie had no evidence of cancer at the 5-year treatment mark after Stage III hormone-sensitive breast cancer treatment and later had twins after ovarian function returned.

Cleveland ClinicRead more →

Phrenic nerve palsy after repeated radiation for left breast cancer

Patient Info: Anonymized, Female, 60s | Stage I

She was discharged on room air after steroid treatment improved the hypoxia associated with right diaphragmatic weakness.

PubMed CentralRead more →

BRCA Breast Cancer: Christie's Patient Story

Patient Info: Christie Siebel, female, Under 40

Biomarkers: BRCA mutation

At the latest update, Christie was doing well and attending annual breast cancer follow-up visits.

MD AndersonRead more →

Triple-Negative Breast Cancer: Sandra's Survivor Story

Patient Info: Sandra Monsonís, Female, 40s

Biomarkers: Triple-negative breast cancer; BRCA-positive

As of November 2021, Sandra felt healthy and happy after treatment for triple-negative breast cancer, BRCA-positive testing, double mastectomy, implant complication care, external prosthesis, and ovary removal to reduce future cancer risk.

Breast Cancer: Theresa's Patient Story

Patient Info: Theresa Reynolds, Female, 70+

As of October 2021, Theresa had gone through mastectomy and radiation for breast cancer with coordinated support from her care team; stage, subtype and recurrence status were not reported.

Cleveland ClinicRead more →

Stage I Invasive Ductal Carcinoma: Kim's Survivor Story

Patient Info: Kim Brisky, Female | Stage I

As of October 2021, Kim had completed chemotherapy and double mastectomy with reconstruction for Stage I ductal breast cancer, with clean margins and no signs of cancer after surgery.

Cleveland ClinicRead more →

BRCA1 Breast Cancer: Muriel's Survivor Story

Patient Info: Muriel Verger, Female, Under 40

Biomarkers: BRCA1 mutation

As of October 2021, Muriel described having completed about 9 months of treatment for triple-negative breast cancer diagnosed in 2015 and focused her message on survivorship, body image, and early detection.

YouTube (FR search)Read more →

Stage I HER2-Positive Invasive Ductal Carcinoma: Tammy's Patient Story

Patient Info: Tammy, Female | Stage I

Biomarkers: HER2-positive; triple-positive breast cancer

As of September 2021, this story segment described the start of Tammy’s adjuvant treatment plan after HER2-positive, triple-positive Stage I invasive ductal carcinoma was found; no later outcome was stated in this record.

YouTube — Tammy Salamone - The Pink SurvivorRead more →

Invasive Lobular Carcinoma: Maureen's Patient Story

Patient Info: Maureen, Female

Biomarkers: Breast Cancer Index test used to guide duration of anti-estrogen therapy

Maureen completed double mastectomy and 30 radiation treatments for pleomorphic ILC and planned 10 years of anti-estrogen therapy based on Breast Cancer Index testing.

Lobular Breast Cancer AllianceRead more →

Stage III HR-Positive Invasive Lobular Carcinoma: Jeanine's Patient Story

Patient Info: Jeanine, Female | Stage III

Biomarkers: ER-positive; PR-positive; HER2-negative; genetic testing negative

Jeanine completed chemotherapy, bilateral mastectomy, and post-surgery radiation after her disease was restaged from Stage II to Stage III, and she described continued active oncology care and advocacy as of June 2021.

Lobular Breast Cancer AllianceRead more →

Invasive Lobular Carcinoma: Susie's's Patient Story

Patient Info: Susie's daughter, Female, 40s

As of May 2021, Susie’s daughter was living after treatment for an 8 cm invasive lobular carcinoma and dealing with side effects from different endocrine therapies, while Susie became active in ILC advocacy and research support.

Lobular Breast Cancer AllianceRead more →

Male breast cancer discovered after years of stiff-person syndrome

Patient Info: Anonymized, Male, 50s

Biomarkers: ER-positive; PR-positive; HER2-negative; anti-amphiphysin antibody positive at 1:64; hereditary cancer panel negative for pathogenic germline variants.

He completed curative-intent breast cancer treatment and reported substantial improvement in upper-body stiffness, although lower-extremity stiffness, cramps, and unsteadiness persisted.

PubMed CentralRead more →

Breast cancer returned in the stomach and peritoneum after three years in remission

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Biomarkers: Initial breast tumor: ER 95%, PR 5%, HER2-negative, Nottingham grade 2. Metastatic peritoneal tumor: ER 80%

Metastatic Site: stomach; peritoneum

After metastatic breast cancer was confirmed in the stomach and peritoneum, she chose palliative care and inpatient hospice and died a few weeks later.

PubMed CentralRead more →

Breast cancer with sarcoidosis that mimicked metastatic disease

Patient Info: Anonymized, Female, 40s

Biomarkers: ER-positive; PR-positive; HER2-negative.

Her most recent mammogram showed no recurrent breast cancer while she continued letrozole, goserelin, and six-monthly follow-up.

PubMed CentralRead more →

Invasive Lobular Carcinoma: Hillary's Survivor Story

Patient Info: Hillary, Female, 50s

As of April 2021, Hillary had completed surgery, chemotherapy, radiation, lymphedema rehabilitation and staged reconstruction for node-positive breast cancer, with return toward normal life; no formal stage or NED status was stated.

Cleveland ClinicRead more →

Primary small-cell neuroendocrine breast cancer treated with mastectomy

Patient Info: Anonymized, Female, 40s

Biomarkers: ER-negative; HER2 not overexpressed; Ki-67 90%; synaptophysin-positive; chromogranin A-positive; TTF-1-positive.

Her postoperative recovery was uncomplicated, and she was referred for adjuvant oncology after chemotherapy and radiation were recommended.

PubMed CentralRead more →

Adenoid cystic cancer of the left breast treated with bilateral mastectomy and tamoxifen

Patient Info: Anonymized, Female, 60s

Biomarkers: BRCA1/2 negative for known pathogenic variants.

The left adenoid cystic carcinoma had not recurred, although a biologically distinct second primary later developed in right axillary ectopic breast tissue.

PubMed CentralRead more →

HER2-positive left breast cancer treated with trastuzumab and mastectomy

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Biomarkers: ER-negative; PR-negative; HER2/CerbB2 strongly positive; BRCA1/2 negative for known pathogenic variants; FANCA variant of uncertain significance.

She remained alive, asymptomatic, and disease-free while undergoing annual surveillance after treatment for the left HER2-positive breast cancer.

PubMed CentralRead more →

Right lobular carcinoma in situ found during follow-up for earlier breast cancer

Patient Info: Anonymized, Female, 60s

Biomarkers: BRCA1/2 negative for known pathogenic variants; FANCA variant of uncertain significance.

She remained alive, asymptomatic, and disease-free while continuing annual laboratory and imaging surveillance.

PubMed CentralRead more →

Recovery from severe bowel and oesophageal complications after breast cancer chemotherapy

Patient Info: Anonymized, Female, 40s

Biomarkers: HER2-positive.

She regained independence after an 89-day hospital course, but breast surgery remained deferred three months after intensive-care discharge and tamoxifen was being used during recovery.

PubMed CentralRead more →

Local Breast Cancer Recurrence Was Found During BioZorb Surveillance

Patient Info: Anonymized, Female, 70+

Biomarkers: Initial right breast tumor: ER-positive, PR-positive, HER2-equivocal. Recurrent right breast tumor: ER-positive, HER2-negative.

Two sites of right-breast recurrence were confirmed three years after lumpectomy, leading to right mastectomy.

PubMed CentralRead more →